Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- Status
- RECRUITING
- Phase
- PHASE3
Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)
- Status
- COMPLETED
- Phase
- N/A
Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA
- Status
- TERMINATED
- Phase
- PHASE2
Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)
- Status
- COMPLETED
- Phase
- N/A
Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- N/A
A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]
- Status
- TERMINATED
- Phase
- PHASE2
Resection Observatory
- Status
- COMPLETED
- Phase
- N/A
BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back Pain
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis
- Status
- TERMINATED
- Phase
- PHASE3
Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan
- Status
- COMPLETED
- Phase
- PHASE3